PT2854768T - Composições farmacêuticas de pemetrexed - Google Patents
Composições farmacêuticas de pemetrexedInfo
- Publication number
- PT2854768T PT2854768T PT137300703T PT13730070T PT2854768T PT 2854768 T PT2854768 T PT 2854768T PT 137300703 T PT137300703 T PT 137300703T PT 13730070 T PT13730070 T PT 13730070T PT 2854768 T PT2854768 T PT 2854768T
- Authority
- PT
- Portugal
- Prior art keywords
- pemetrexed
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1648DE2012 | 2012-05-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2854768T true PT2854768T (pt) | 2017-05-19 |
Family
ID=48656253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT137300703T PT2854768T (pt) | 2012-05-30 | 2013-05-30 | Composições farmacêuticas de pemetrexed |
Country Status (8)
Country | Link |
---|---|
US (2) | US9421207B2 (pt) |
EP (2) | EP2854768B1 (pt) |
DK (1) | DK2854768T3 (pt) |
ES (1) | ES2624442T3 (pt) |
LT (1) | LT2854768T (pt) |
PT (1) | PT2854768T (pt) |
SI (1) | SI2854768T1 (pt) |
WO (1) | WO2013179248A1 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014167585A1 (en) * | 2013-04-12 | 2014-10-16 | Actavis Group Ptc Ehf. | Pemetrexed formulation |
KR101485243B1 (ko) * | 2013-05-08 | 2015-01-21 | 씨제이헬스케어 주식회사 | 안정화된 페메트렉시드 제제 |
WO2014198337A1 (en) * | 2013-06-14 | 2014-12-18 | Synthon B.V. | Stable and water soluble pharmaceutical compositions comprising pemetrexed |
JP2016527227A (ja) * | 2013-07-16 | 2016-09-08 | ドクター レディズ ラボラトリーズ リミテッド | ペメトレキセドトロメタミン塩の新規な結晶形 |
CN105611932B (zh) | 2013-10-03 | 2019-02-12 | 富士胶片株式会社 | 注射液制剂及其制造方法 |
JP6120766B2 (ja) * | 2013-12-27 | 2017-04-26 | 富士フイルム株式会社 | 注射液製剤及びその製造方法 |
PL3124026T3 (pl) * | 2014-03-28 | 2019-03-29 | Fujifilm Corporation | Preparat iniekcyjny i sposób jego wytwarzania |
GB201418555D0 (en) * | 2014-10-16 | 2014-12-03 | Teva Gmbh | Pemetrexed formulations |
PL3206666T3 (pl) * | 2014-10-16 | 2020-09-21 | Synthon B.V. | Ciekła kompozycja farmaceutyczna zawierająca pemetreksed |
JP6869899B2 (ja) * | 2015-02-13 | 2021-05-12 | サン・ファーマシューティカル・インダストリーズ・リミテッド | 静脈内注入剤形 |
KR101919436B1 (ko) * | 2015-05-28 | 2018-11-16 | 주식회사 삼양바이오팜 | 안정화된 약학 조성물 및 그의 제조방법 |
GB201511246D0 (en) * | 2015-06-25 | 2015-08-12 | Actavis Group Ptc Ehf | Pharmaceutical formulation |
KR101693675B1 (ko) * | 2015-12-14 | 2017-01-06 | 주식회사 종근당 | 페메트렉시드 또는 그의 약제학적으로 허용가능한 염을 함유하는 안정화된 약학조성물 |
US20170239250A1 (en) | 2016-02-19 | 2017-08-24 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
AU2016393213B2 (en) * | 2016-02-19 | 2022-03-31 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
US20200246263A1 (en) * | 2017-08-29 | 2020-08-06 | Fresenius Kabi Oncology Limited | Stable liquid compositions of pemetrexed |
PL3470045T3 (pl) | 2017-10-10 | 2021-03-08 | Sun Pharmaceutical Industries Ltd | Dożylna infuzyjna postać dawkowania dla pemetreksedu |
CN108158989B (zh) * | 2018-03-01 | 2020-08-28 | 河北爱尔海泰制药有限公司 | 一种盐酸氨溴索注射液组合物 |
US10966982B2 (en) * | 2018-11-20 | 2021-04-06 | Cipla Limited | Stable pharmaceutical formulations of pemetrexed |
WO2020222151A1 (en) * | 2019-05-01 | 2020-11-05 | Intas Pharmaceuticals Ltd. | A stable, ready to use aqueous pharmaceutical composition of pemetrexed |
WO2021192472A1 (ja) * | 2020-03-24 | 2021-09-30 | ナガセ医薬品株式会社 | ペメトレキセド製剤 |
JP7282065B2 (ja) * | 2020-10-05 | 2023-05-26 | イーグル ファーマシューティカルズ, インコーポレイテッド | ペメトレキセド製剤 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02502534A (ja) | 1987-12-18 | 1990-08-16 | チバ‐ガイギー アクチェンゲゼルシャフト | 1‐メチル‐β‐オキソ‐α‐(フェニルカルバモイル)‐2‐ピロールプロピオニトリルのトロメタミン塩 |
IL96531A (en) | 1989-12-11 | 1995-08-31 | Univ Princeton | History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) |
KR0162654B1 (ko) | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체 |
US6686365B2 (en) | 2000-02-04 | 2004-02-03 | Eli Lilly And Company | Pharmaceutical composition |
WO2002002093A2 (en) | 2000-06-30 | 2002-01-10 | Eli Lilly And Company | Combination containing an antifolate and methylmalonic acid lowering agent |
CN100364993C (zh) | 2003-05-30 | 2008-01-30 | 江苏恒瑞医药股份有限公司 | 培美曲噻盐及其制备方法 |
EP1818049A3 (en) | 2006-02-10 | 2008-11-19 | LifeCycle Pharma A/S | Stabilized Atorvastatin |
CN101081301A (zh) | 2006-05-29 | 2007-12-05 | 海南天源康泽医药科技有限公司 | 含有培美曲塞的药物组合物 |
US8629152B2 (en) | 2006-08-14 | 2014-01-14 | Sicor, Inc. | Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid |
WO2010030598A2 (en) | 2008-09-11 | 2010-03-18 | Dr. Reddy's Laboratories Limited | Pharmaceutical formulations comprising pemetrexed |
IT1401207B1 (it) | 2010-06-30 | 2013-07-12 | Magic Production Group S A | Dispositivo e procedimento per la chiusura di contenitori |
WO2012015810A2 (en) | 2010-07-28 | 2012-02-02 | Eagle Pharmaceuticals, Inc. | Pharmaceutical compositions containing pemetrexed having extended storage stability |
WO2014167585A1 (en) | 2013-04-12 | 2014-10-16 | Actavis Group Ptc Ehf. | Pemetrexed formulation |
-
2013
- 2013-05-30 SI SI201330666T patent/SI2854768T1/sl unknown
- 2013-05-30 WO PCT/IB2013/054456 patent/WO2013179248A1/en active Application Filing
- 2013-05-30 EP EP13730070.3A patent/EP2854768B1/en active Active
- 2013-05-30 DK DK13730070.3T patent/DK2854768T3/en active
- 2013-05-30 ES ES13730070.3T patent/ES2624442T3/es active Active
- 2013-05-30 EP EP17161417.5A patent/EP3210629A1/en not_active Withdrawn
- 2013-05-30 PT PT137300703T patent/PT2854768T/pt unknown
- 2013-05-30 LT LTEP13730070.3T patent/LT2854768T/lt unknown
- 2013-05-30 US US14/403,310 patent/US9421207B2/en active Active
-
2016
- 2016-07-01 US US15/200,433 patent/US9968608B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US9421207B2 (en) | 2016-08-23 |
EP3210629A1 (en) | 2017-08-30 |
US20150111905A1 (en) | 2015-04-23 |
DK2854768T3 (en) | 2017-06-12 |
WO2013179248A1 (en) | 2013-12-05 |
ES2624442T3 (es) | 2017-07-14 |
US20160310495A1 (en) | 2016-10-27 |
SI2854768T1 (sl) | 2017-08-31 |
US9968608B2 (en) | 2018-05-15 |
LT2854768T (lt) | 2017-06-12 |
EP2854768B1 (en) | 2017-03-22 |
EP2854768A1 (en) | 2015-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201703992B (en) | Inhalable pharmaceutical compositions | |
SI2854768T1 (sl) | Farmacevtski sestavki pemetrekseda | |
HK1209638A1 (en) | Pharmaceutical compositions | |
GB201113662D0 (en) | Pharmaceutical compositions | |
ZA201308208B (en) | Pharmaceutical compositions | |
HK1199824A1 (en) | Pharmaceutical compositions | |
ZA201501930B (en) | Pharmaceutical composition | |
EP2832730A4 (en) | MIRABEGRAPHIC PHARMACEUTICAL COMPOSITION | |
EP2917314A4 (en) | OLIGOMERATZUSAMMENSETZUNG | |
IL266415A (en) | Innovative pharmaceutical composition | |
IL237139A0 (en) | Pharmaceutical compositions of memantine | |
PL2887924T3 (pl) | Kompozycje farmaceutyczne etorykoksybu | |
GB201118181D0 (en) | Pharmaceutical compositions | |
ZA201502987B (en) | Pharmaceutical composition | |
EP2897590A4 (en) | PHARMACEUTICAL COMPOSITION | |
GB201211153D0 (en) | Pharmaceutical compositions | |
EP2884964A4 (en) | PHARMACEUTICAL COMPOSITION OF PROPOFOL | |
EP2851078A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP2714715A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
IL238075A0 (en) | pharmaceutical preparations | |
GB201219234D0 (en) | Pharmaceutical compositions | |
GB201213303D0 (en) | Pharmaceutical compositions | |
GB201204810D0 (en) | Pharmaceutical compositions | |
ZA201400751B (en) | Pharmaceutical composition |